Recent news on Olopatadine Hydrochloride

Kyowa Hakko Fiscal 2006 Operating Income up 20.2%  -  Apr 26, 2007
Genetic Engineering News (press release),...but sales of Allelock (olopatadine hydrochloride) an antiallergic agent, Durotep Patch, an analgesic for persistent cancer pain, and Navelbine,

Kyowa Hakko Nine-month Operating Income up 17.5%  -  Jan 29, 2007
PharmaLive.com (press release),Despite pharmaceutical price cuts introduced in April 2006, higher sales volumes of Allelock (olopatadine hydrochloride), an antiallergic agent,

Tussentijdse bedrijfsinkomsten Kyowa Hakko 18,4 procent gestegen  Oct 29, 2006
...of prescription pharmaceuticals such as Coniel, a treatment for hypertension and angina pectoris, and Allelock (olopatadine hydrochloride), an antiallergic ... -Netherlands Corporate News (persbericht), Alcon Sues Apotex to Block Sales of Generic Patanol (Update1)  -  Nov 16, 2006
BloombergApotex is seeking US Food and Drug Administration approval to sell a copy of the treatment, whose key ingredient is olopatadine hydrochloride.

Patanol(R) (Olopatadine Hydrochloride Ophthalmic Solution) ...  Jul 27, 2006
...approval from the Ministry of Health, Labor and Welfare in Japan to market its eye allergy drug, Patanol® (olopatadine hydrochloride ophthalmic solution) 0.1 ... -DG News

Alcon, Inc. (ACL) Receives Approval from Ministry of Health in ...  Jul 26, 2006
...approval from the Ministry of Health, Labor and Welfare in Japan to market its eye allergy drug, PATANOL® (olopatadine hydrochloride ophthalmic solution) 0.1 ... -StreetInsider.com (subscription)

Alcon Japan, Kyowa Hakko Kogyo to Join Hands in Sales and ...  Jun 29, 2006
Tokyo, June 29, 2006 (JCN) - Alcon Japan and Kyowa Hakko Kogyo have signed an agreement for the olopatadine hydrochloride ophthalmic solution, a prescription ... -Japan Corporate News



Kyowa Hakko Profits Decline on Higher R&D Spend but Recurring ...  Apr 27, 2006
Allelock, an antiallergic agent (olopatadine hydrochloride),Durotep Patch, an analgesic for persistent cancer pain, and Navelbine,an anticancer agent, each ... - Finanzen.net





Alcon Labs withdraws EU allergy spray application  Feb 24, 2006
Opatanol (olopatadine hydrochloride) was first authorized in the European Union in May 2002 as eye drops for the treatment of ocular signs and symptoms of ... - Pharmaceutical Business Review

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional